Aurello Paolo, D'Angelo Francesco, Rossi Simone, Bellagamba Riccardo, Cicchini Claudia, Nigri Giuseppe, Ercolani Giorgio, De Angelis Renato, Ramacciato Giovanni
University of Rome, La Sapienza, Second Faculty of Medicine, Sant'Andrea Hospital, Surgery Unit D, 00189 Rome, Italy.
Am Surg. 2007 Apr;73(4):359-66.
The tumor, node, metastasis (TNM) system has become the principal method for assessing the extent of disease, determining prognosis in gastric cancer patients, and affecting the therapy strategies. The extent of lymph node metastasis is the most important prognostic factor. The aim of this study was to compare the N-classifications of the 4th and the 5th-6th TNM editions and to evaluate retrospectively the prognostic value of the 2002 TNM edition. We evaluated 344 patients who underwent curative total or subtotal gastrectomy. Nodal involvement was detected in 221 (64%) patients. Median follow-up period was 76 months. Thirty per cent of the old N1 patients were reclassified as pN2 (18.5%) and pN3 (11.3%). Eighty-eight per cent of the old N2 patients were reclassified as pN1 (75%) and pN3 (13.7%). In reclassifying the patients, statistically significant changes were reported between 1987 and 2002 TNM stage grouping, mainly in stage IIIB and IV. The 5-year survival rate per stage group did not statistically differ between the 4th and the 5th-6th editions, although a diminutive trend was registered in the IIIA stage. pTNM stage, nodal numerical stage, nodal topographical stage, and depth of tumor invasion resulted in significantly independent prognostic factors. Our data confirm the simplicity and easy application of the new stadiation and the better prognostic stratification of the N-stage. The pN3 group showed a worse prognosis independent of location. On the other hand, prognostic value of pN1 and pN2 stage is lower, probably depending on lymph node location. In multivariate analysis, the difference between old and new TNM staging is low. Hence, we suggest comparing lymph node location and number in larger series. In our series, in pT1 tumors, neither pN2 nor pN3 involvement was found. Hence, in our opinion, for correct N-staging, 10 lymph nodes in early gastric cancer and at least 16 in the other pT-stages seem sufficient for a real pN0 stadiation.
肿瘤、淋巴结、转移(TNM)系统已成为评估疾病范围、确定胃癌患者预后以及影响治疗策略的主要方法。淋巴结转移范围是最重要的预后因素。本研究的目的是比较第4版和第5 - 6版TNM的N分类,并回顾性评估2002年TNM版的预后价值。我们评估了344例行根治性全胃或次全胃切除术的患者。221例(64%)患者检测到淋巴结受累。中位随访期为76个月。30%的旧N1期患者重新分类为pN2(18.5%)和pN3(11.3%)。88%的旧N2期患者重新分类为pN1(75%)和pN3(13.7%)。在对患者进行重新分类时,报告了1987年和2002年TNM分期分组之间具有统计学意义的变化,主要在IIIB期和IV期。尽管在IIIA期有轻微趋势,但各期组的5年生存率在第4版和第5 - 6版之间无统计学差异。pTNM分期、淋巴结数字分期、淋巴结拓扑分期和肿瘤浸润深度均为显著独立的预后因素。我们的数据证实了新分期的简单性和易于应用以及N分期更好的预后分层。pN3组显示出与位置无关的更差预后。另一方面,pN1和pN2期的预后价值较低,可能取决于淋巴结位置。在多变量分析中,新旧TNM分期之间的差异较小。因此,我们建议在更大系列中比较淋巴结位置和数量。在我们的系列中,在pT1肿瘤中,未发现pN2或pN3受累。因此,我们认为,为了正确进行N分期,早期胃癌10个淋巴结以及其他pT分期至少16个淋巴结似乎足以实现真正的pN0分期。